<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03268031</url>
  </required_header>
  <id_info>
    <org_study_id>ProjectAGE</org_study_id>
    <nct_id>NCT03268031</nct_id>
  </id_info>
  <brief_title>Artificial Intelligence-assissted Glaucoma Evaluation</brief_title>
  <acronym>AGE</acronym>
  <official_title>Development of Artificial Intelligence-assissted Diagnostic Program of Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese Academy of Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glaucoma is currently the second leading cause of irreversible blindness in the world. Our
      study intends to combine clinical data of glaucoma patients in Zhongshan Ophthalmic Center
      with Artificial Intelligence techniques to create programs that can screen and diagnose
      glaucoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Glaucoma is currently the second leading cause of irreversible blindness in the world, which
      brings heavy burden to human society. Compared to other ocular diseases, diagnostic process
      of glaucoma is complicated depends on multiple test results, including visual field test,
      OCT, etc. How to diagnose glaucoma correctly and fast has always been a hot topic in glaucoma
      researches. Artificial intelligence is used to study and develop theories and methods that
      can help simulate and extend human intelligence, which has been utilized in a lot of research
      fields such as automatic drive and medicine. The study intends to combine clinical data of
      glaucoma patients in Zhongshan Ophthalmic Center with Artificial Intelligence techniques to
      create programs that can screen and diagnose glaucoma.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of diagnosis by artificial intelligence program</measure>
    <time_frame>from August 2017 to February 2019</time_frame>
    <description>Accuracy of diagnosis by artificial intelligence program and compare this result with glaucoma specialists</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of diagnosis by artificial intelligence program</measure>
    <time_frame>from August 2017 to February 2019</time_frame>
    <description>Sensitivity of diagnosis by artificial intelligence program</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of diagnosis by artificial intelligence program</measure>
    <time_frame>from August 2017 to February 2019</time_frame>
    <description>Specificity of diagnosis by artificial intelligence program</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Artificial Intelligence</condition>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Glaucoma patients</arm_group_label>
    <description>Glaucoma patients will take visual field test and OCT imaging of optic nerve area. All of these data will be collected as source of machine learning.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-glaucoma participants</arm_group_label>
    <description>Non-glaucoma participants will take visual field test and OCT imaging of optic nerve area. All of these data will be collected as source of machine learning.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Visual field test</intervention_name>
    <description>Visual field test and OCT are commonly used essential tests to make accurate diagnosis of glaucoma.</description>
    <arm_group_label>Glaucoma patients</arm_group_label>
    <arm_group_label>Non-glaucoma participants</arm_group_label>
    <other_name>Optical coherence tomography</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Anyone who can complete visual field test and have BCVA&gt;0.1 can be enrolled. We will
        collect visual field test result and OCT images of both glaucoma and non-glaucoma patients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. BCVA&gt;0.1

          2. able to complete reliable visual field test

          3. no history of intraocular surgery or fundus laser

        Exclusion Criteria:

        1. unable to complete visual field test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiulan Zhang, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiulan Zhang, Doctor</last_name>
    <phone>8613570166308</phone>
    <email>xiulan_z@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fei Li, Doctor</last_name>
    <phone>8613602299295</phone>
    <email>283630360@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiulan Zhang, Doctor</last_name>
      <phone>8613570166308</phone>
      <email>xiulan_z@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Diprose W, Buist N. Artificial intelligence in medicine: humans need not apply? N Z Med J. 2016 May 6;129(1434):73-6.</citation>
    <PMID>27349266</PMID>
  </results_reference>
  <results_reference>
    <citation>Quigley HA. Glaucoma. Lancet. 2011 Apr 16;377(9774):1367-77. doi: 10.1016/S0140-6736(10)61423-7. Epub 2011 Mar 30. Review.</citation>
    <PMID>21453963</PMID>
  </results_reference>
  <results_reference>
    <citation>Asaoka R, Murata H, Iwase A, Araie M. Detecting Preperimetric Glaucoma with Standard Automated Perimetry Using a Deep Learning Classifier. Ophthalmology. 2016 Sep;123(9):1974-80. doi: 10.1016/j.ophtha.2016.05.029. Epub 2016 Jul 7.</citation>
    <PMID>27395766</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2017</study_first_submitted>
  <study_first_submitted_qc>August 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2017</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>xiulan zhang</investigator_full_name>
    <investigator_title>Director of Clinical Research Center</investigator_title>
  </responsible_party>
  <keyword>artificial intelligence</keyword>
  <keyword>glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

